ARCHIVES

Controversy Continues, Scientists, Advocates, Clinicians Say

This article is from The Cancer Letter archive.

Vol. 23 No. 04 | January 31, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment

May 4, 2012

BSA Approves Trial of Carbon Ion Therapy, Extends EDRN And Provocative Questions

July 4, 2014

Senate Subcommittee Seeking $2 Billion In for NIH, Bumps Up Against Caps

June 25, 1999

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

NCI Advisory Group, Other Cancer Meetings for Oct., Nov., Future

September 29, 1989

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006